The company told the American Diabetes Association the metabolic monitor could reduce down-the-line healthcare costs for T2 non-insulin users and others. "These trends have to change," says CEO Kevin Sayer.
Subscribe to:
Post Comments (Atom)
< + > Bringing AI Agents to Healthcare with Anshar AI
In our recent interview with Pinaki Saha, CEO & Founder at Anshar AI , he put some numbers on the problems that are commonly cited in he...
No comments:
Post a Comment